Press Releases

May 14, 2019

ProMIS Neurosciences Announces First Quarter 2019 Results

April 23, 2019

ProMIS Neurosciences to Participate in the Think Equity Investor Conference

March 26, 2019

ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019

Press Archives

In the News

February 28, 2019

Genetic Engineering and Biotechnology News – Attacking the Right Therapeutic Target in Alzheimer’s Disease

February 1, 2019

CANTECH LETTER – Could Roche’s Alzheimer’s drug failure be Promis Neurosciences gain?

December 18, 2018

DDN News – ProMIS tackles Parkinson’s and Alzheimer’s diseases

News Archives

Presentations

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

Presentations Archives

Videos

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

Video Archives